HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Friedrich W. Mohr Thomas Walther Volkmar Falk Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mohr, F. W. Articles by Dalichau, H. Search for Related Content PubMed PubMed Citation Articles by Mohr, F. W. Articles by Dalichau, H.

Ann Thorac Surg 1995;60:171-175
© 1995 The Society of Thoracic Surgeons

The Toronto SPV Bioprosthesis: One-Year Results in 100 Patients

Department of Thoracic and Cardiovascular Surgery, Georg-August-University Göttingen, Göttingen, Germany

Accepted for publication March 23, 1995.

Background. We studied the long-term results of heart valve replacement with the Toronto SPV bioprosthesis.

Methods. From March 1993 until July 1994 the Toronto stentless bioprosthesis was implanted in 100 selected patients with a mean age of 70.7 years. The predominant aortic valve lesion was stenosis in 94 and insufficiency in 6 cases. Eighty-eight patients received a valve 25 mm in diameter or larger. Additional coronary artery bypass grafting was performed in 37 cases. Hospital mortality was 4%. Seventy-four patients were seen at 6 months and 38 patients at 1 year follow-up.

Results. Structural deterioration, thromboembolism or hemorrhage were not encountered. Nonstructural dysfunction lead to reoperation in 1 patient. Another patient presented with endocarditis at 1 year postoperatively. There were no other valve-related complications. Echocardiographic mean pressure gradients ranged from 7.7 to 11.1 mm Hg postoperatively. There was a significant decrease in pressure gradients at 6 months of follow-up. Minimal aortic valve incompetence was seen in 3 patients.

Conclusions. The Toronto stentless bioprosthesis has superior hemodynamics and is an excellent alternative to conventional stented bioprostheses. Long-term evaluation has to prove whether this promising new valve can live up to its expectations.

This article has been cited by other articles:

				S. Lehmann, T. Walther, J. Kempfert, S. Leontjev, A. Rastan, V. Falk, and F. W. Mohr Stentless Versus Conventional Xenograft Aortic Valve Replacement: Midterm Results of a Prospectively Randomized Trial Ann. Thorac. Surg., August 1, 2007; 84(2): 467 - 472. [Abstract] [Full Text] [PDF]

				J. B. Chambers, H. M. Rimington, F. Hodson, R. Rajani, and C. I. Blauth The subcoronary Toronto stentless versus supra-annular Perimount stented replacement aortic valve: Early clinical and hemodynamic results of a randomized comparison in 160 patients J. Thorac. Cardiovasc. Surg., April 1, 2006; 131(4): 878 - 882. [Abstract] [Full Text] [PDF]

				M. Tamim, T. Bove, Y. Van Belleghem, K. Francois, Y. Taeymans, and G. J Van Nooten Stentless vs. Stented Aortic Valve Replacement: Left Ventricular Mass Regression Asian Cardiovasc Thorac Ann, June 1, 2005; 13(2): 112 - 118. [Abstract] [Full Text] [PDF]

				W. B. Eichinger, F. Botzenhardt, R. Gunzinger, B. M. Kemkes, A. Sosnowski, D. Maiza, E. O. Coto, and N. Bleese European experience with the Mosaic bioprosthesis J. Thorac. Cardiovasc. Surg., August 1, 2002; 124(2): 333 - 339. [Abstract] [Full Text] [PDF]

				P. Pibarot and J. G. Dumesnil Hemodynamic and clinical impact of prosthesis-patient mismatch in the aortic valve position and its prevention J. Am. Coll. Cardiol., October 1, 2000; 36(4): 1131 - 1141. [Abstract] [Full Text] [PDF]

				T. Walther, V. Falk, G. Langebartels, M. Kruger, U. Bernhardt, A. Diegeler, J. Gummert, R. Autschbach, and F. W. Mohr Prospectively Randomized Evaluation of Stentless Versus Conventional Biological Aortic Valves : Impact on Early Regression of Left Ventricular Hypertrophy Circulation, November 9, 1999; 100(90002): II-6 - 10. [Abstract] [Full Text] [PDF]

				K. L. Yun, C. F. Sintek, A. D. Fletcher, T. A. Pfeffer, G. S. Kochamba, M. R. Hyde, J. O. Torpoco, and S. Khonsari Aortic Valve Replacement With the Freestyle Stentless Bioprosthesis : Five-Year Experience Circulation, November 9, 1999; 100(90002): II-17 - 23. [Abstract] [Full Text] [PDF]

				K. Furukawa, H. Ohteki, Z.-L. Cao, K. Doi, Y. Narita, N. Minato, and T. Itoh Does dilatation of the sinotubular junction cause aortic regurgitation? Ann. Thorac. Surg., September 1, 1999; 68(3): 949 - 953. [Abstract] [Full Text] [PDF]

				J. A. M. van Son, R. Battellini, M. Mierzwa, T. Walther, R. Autschbach, and F. W. Mohr AORTIC ROOT RECONSTRUCTION WITH PRESERVATION OF NATIVE AORTIC VALVE AND SINUSES IN AORTIC ROOT DILATATION WITH AORTIC REGURGITATION J. Thorac. Cardiovasc. Surg., June 1, 1999; 117(6): 1151 - 1155. [Abstract] [Full Text] [PDF]

				P. Bertolini, G. B. Luciani, B. Vecchi, P. Pugliese, and A. Mazzucco Aortic valve replacement with the biocor PSB stentless xenograft Ann. Thorac. Surg., August 1, 1998; 66(2): 425 - 430. [Abstract] [Full Text] [PDF]

				G. Bhatnagar, G. T. Christakis, P. M. Murphy, D. Oxorn, and B. S. Goldman Technique for Reconstruction of the Sinotubular Junction Ann. Thorac. Surg., February 1, 1997; 63(2): 559 - 560. [Abstract] [Full Text]

				D. F. Del Rizzo, B. S. Goldman, G. T. Christakis, and T. E. David HEMODYNAMIC BENEFITS OF THE TORONTO STENTLESS VALVE J. Thorac. Cardiovasc. Surg., December 1, 1996; 112(6): 1431 - 1446. [Abstract] [Full Text]

				X. Y. Jin, Z.-M. Zhang, D. G. Gibson, M. H. Yacoub, and J. R. Pepper Effects of Valve Substitute on Changes in Left Ventricular Function and Hypertrophy After Aortic Valve Replacement Ann. Thorac. Surg., September 1, 1996; 62(3): 683 - 690. [Abstract] [Full Text]